CTSL and glioblastoma: For example, KGP94, a small molecule inhibitor of CTSL, has shown good therapeutic effects in vitro against the breast and prostate cell lines [77], and we speculate that inhibition of CTSL in GBM may likewise be an effective targeted therapeutic approach.